Participant characteristics and outcomes according to RE-AIM framework
| Reach | ||
| Total referrals | 100 | |
| Attended initial assessment | 71 | |
| Number of home visits per patient | 1 (1–4) | |
| Number of phone calls per patient | 7 (3–7) | |
| Completion | 53 | |
| Characteristics | ||
| Age years | 71±12 | |
| Male/female | 28/43 | |
| FEV1 % predicted | 57±22 | |
| Long-term oxygen therapy | 13 | |
| Diagnoses | ||
| COPD | 49 | |
| Asthma | 8 | |
| Bronchiectasis | 7 | |
| Interstitial lung disease | 4 | |
| Pulmonary hypertension | 2 | |
| Cystic fibrosis | 1 | |
| Reason for HBPR choice | ||
| Symptom limitation | 32 | |
| Work commitments | 24 | |
| Transportation | 15 | |
| Effectiveness | ||
| Outcomes | Baseline | Change following HBPR (n=53) |
| 6MWD m | 360 (218–541) | 24 (6–34)# |
| CRQ score | ||
| Dyspnoea | 15 (10–18) | 3 (1–5)# |
| Fatigue | 15 (11–18) | 2 (1–3)# |
| Emotional function | 35 (28–39) | 2 (0–3) |
| Mastery | 20 (16–23) | 2 (1–3)# |
| CAT score | 18 (13–22) | −2 (−3–1)# |
| HADS score | ||
| Anxiety | 5 (2–9) | −1 (−2–0) |
| Depression | 5 (2–9) | 0 (−2–1) |
| mMRC score | 2 (1–3) | 34 (64%) score unchanged |
| 19 (36%) score improved | ||
| Adoption | ||
| Staff trained | 7 | |
| Implementation | ||
| Programme modification | 20 | |
| Pedometer use | 20 | |
| Home diary completion | 46 | |
| Maintenance | ||
| Pilot period 1 year | >3 years | |
Data are n, median (interquartile range) or mean±sd. n=71 unless otherwise stated. RE-AIM: Reach, Effectiveness, Adoption, Implementation, Maintenance; FEV1: forced expiratory volume in 1 s; COPD: chronic obstructive pulmonary disease; HBPR: home-based pulmonary rehabilitation; 6MWD: 6-min walk distance; CRQ: Chronic Respiratory Questionnaire; CAT: COPD Assessment Test; HADS: Hospital Anxiety and Depression Scale; mMRC: modified Medical Research Council dyspnoea scale. #: clinically important change.